C

Leveraging AI Methods to Detect Cognitive Decline and Dementia Over the Telephone: A Promising New Screening Tool

By Catherine Diaz-Asper
265 views
November 8, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
19:54
Anton Porsteinsson

Aducanumab FDA Approval for Alzheimer's Disease: The Importance…

57:45
ACHL

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

Feat. J. Galvin
35:24
University of Miami

Lewy Body Dementia: The Most Common Disease You Never Heard Of

Feat. J. Galvin
41:59
ZINCARE

Approach to Cognitive Impairment in Adults

Feat. M. Mataa
30:25
ZINCARE

Cognitive Disorders

Feat. M. Mataa
26:51
2023 Conference Coverage

Updates in Dementia

Feat. P. Tipton
34:59
Lawrence Robbins

Alzheimer's: Clinical Pearls

58:23
Alberto Espay

The Illusion of Progress: Lecanemab in Alzheimer's Disease

11:38
Marc Cohen

The Association Between Herpes Simplex Virus and Alzheimer's Di…

Feat. J. Jagdeo
31:28
University of Miami

Alzheimer’s Disease Variants & Mimics

Feat. D. O'Shea
29:39
Houston Methodist Hospital

Plasma Biomarkers in the Clinic and Clinical Trials

Feat. C. Teunissen
16:01
AD/PD™ International Conference

Cellular Senescence As A Pathogenic Contributor And Therapeutic Targ…

Feat. M. E. Orr
20:14
Banner Alzheimer's Institute

Alzheimer's and Related Dementias: Definitions, Epidemiology, a…

Feat. G. Gopalakrishna
13:53
Jeffrey Cummings

Aducanumab Clinical Application: Patient Selection, Titration, and S…

48:14
Scripps Health

Alzheimer's Dementia Updates

Feat. N. Hwynn
15:16
Campaign to Prevent Alzheimer's disease (PAD 2020)

Diagnosing Dementia

Feat. S. E. Schindler, J. Weiss
50:30
ZINCARE

Alzheimer's Disease

Feat. S. Chirwa
40:16
Bruce L. Miller

bvFTD: The Clinical Syndrome

75:16
Michigan Medicine

What’s New in Alzheimer’s and Related Dementias?

Feat. H. Paulson
59:44
ZINCARE

Alzheimer's Disease: Pathology, Diagnosis, Biomarkers, Therapies

Feat. J. Tanner